Description
ACP 105 research SARM
ACP-105 is a non-steroidal SARM described as a partial agonist of the androgen receptor, studied in preclinical models.
Product details
| Compound | ACP-105 |
|---|---|
| Class | Selective androgen receptor modulator |
| Form | Liquid; Capsules; Tablets |
| Strength | 30ml/33mg per ml/1000mg; 20mg per capsule/60ct/1.2g; 20mg per tablet/27ct/540mg; 20mg per tablet/54ct/1080mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What ACP 105 research has examined
- Partial agonism: androgen receptor activity.
- Tissue selectivity: anabolic versus androgenic endpoints in rats.
- Cognition research: early work in rodent models.
Learn more in What are SARMs?
Regulatory status
ACP 105 is not an approved medicine. The FDA has warned about serious risks from products containing SARMs and similar compounds, and these compounds are prohibited in sport by WADA. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
Ligandrol (LGD-4033) · LGD-3303 · Andarine (S-4) · All SARMs
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.